+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Virus Drug"

Human Immunodeficiency Virus Therapeutics Market by Drug Class, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Human Immunodeficiency Virus Therapeutics Market by Drug Class, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 190 Pages
  • Global
From
Ebola Virus - Competitive Landscape, 2024 - Product Thumbnail Image

Ebola Virus - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Epstein-Barr Virus: Competitive Landscape - Product Thumbnail Image

Epstein-Barr Virus: Competitive Landscape

  • Report
  • August 2024
  • 66 Pages
  • Global
From
Zika Virus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Zika Virus Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 136 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Zika Virus - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Zika Virus - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Zika Virus Therapeutics Market 2024-2028 - Product Thumbnail Image

Zika Virus Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 144 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 182 Pages
  • Global
From
Relapsed/Refractory Epstein Barr Virus - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Relapsed/Refractory Epstein Barr Virus - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • October 2023
  • 75 Pages
  • Global
From
Respiratory Tract Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Respiratory Tract Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 82 Pages
  • Global
From
Rabies Virus - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rabies Virus - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Epstein Barr virus (EBV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Epstein Barr virus (EBV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Virus Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat viral infections. These drugs are designed to target specific viruses, such as HIV, hepatitis, and influenza, and can be used to treat both acute and chronic infections. They can also be used to prevent the spread of viruses, such as through vaccinations. The Virus Drug market is highly competitive, with many companies vying for market share. Companies in the market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, Johnson & Johnson, Bristol-Myers Squibb, and Novartis. These companies are engaged in research and development of new drugs, as well as the marketing and sale of existing drugs. Show Less Read more